Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02723305 · ClinicalTrials.gov registry record

Cardiometabolic Profiles of Boys With Klinefelter Syndrome

A clinical trial of Klinefelter Syndrome and Sex Chromosome Aneuploidy, sponsored by University of Colorado, Denver.

Completed
Registry status
31
Enrollment target
1
Study location

NCT02723305 is a study of Klinefelter Syndrome and Sex Chromosome Aneuploidy that has completed, run by University of Colorado, Denver. The registered enrollment target is 31 participants, below the 281-participant average among 4 other Klinefelter Syndrome trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02723305, a study of Klinefelter Syndrome and Sex Chromosome Aneuploidy, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
31 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such as diabetes, extra weight gain, heart disease and liver diseases.

Interventions

  • OTHER No intervention

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2016-05
Est. Completion 2017-12

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02723305

The ClinicalTrials.gov registry entry for NCT02723305 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 281-participant average among 4 other Klinefelter Syndrome trials with a reported enrollment target (89% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Klinefelter Syndrome appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT02723305 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02723305 about?

NCT02723305 is a clinical study titled "Cardiometabolic Profiles of Boys With Klinefelter Syndrome". This study plans to learn more about how to measure the way the the body's energy system works in boys with Klinefelter syndrome, including the heart, lungs, muscles, and liver. This is important to know so that investigators understand how hormones and an extra X chromosome relate to diseases such ...

What is the current status of trial NCT02723305?

This trial is currently completed. The enrollment target is 31 participants. The study started on 2016-05. Estimated completion is 2017-12.

What conditions does trial NCT02723305 study?

This clinical trial studies the following conditions: Klinefelter Syndrome, Sex Chromosome Aneuploidy, 47,XXY, XXY Syndrome.

What interventions are being tested in trial NCT02723305?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT02723305?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02723305 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Klinefelter Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.